Differential effects of GPA 1851 on hepatic microsomal drug metabolism dependent on dosage and time of sacrifice.
D000814:Aniline Compounds; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000494:pharmacology*; D001463:Barbiturates / Q000494:pharmacology; D001555:Benzene Derivatives / Q000008:administration & dosage / Q000494:pharmacology; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D007093:Imidazoles / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D008780:Methyltransferases / Q000378:metabolism; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D006899:Mixed Function Oxygenases / Q000378:metabolism; D009019:Morphinans; D051381:Rats; D013997:Time Factors
D000814:Aniline Compounds; D000893:Anti-Inflammatory Agents; D001463:Barbiturates; D001555:Benzene Derivatives; D007093:Imidazoles; D009019:Morphinans; C002973:1,4-dimethyl-5-phenyl-2-imidazolinone; D003577:Cytochrome P-450 Enzyme System; D006899:Mixed Function Oxygenases; D008780:Methyltransferases